New MS Treatment Shows Promise in Trial
THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.The drug, called ublituximab, beat a standard oral medic…
Learn MorePsilocybin + Psychotherapy Cuts Heavy Drinking Days in Alcoholism
THURSDAY, Aug. 25, 2022 (HealthDay News) — For adults with alcohol use disorder, psilocybin combined with psychotherapy yields a decrease in the percentage of heavy drinking days compared with active placebo and psychotherapy, according to a study …
Learn MoreIncreasing Level of Alcohol Intake May Raise Risk for Cancer
THURSDAY, Aug. 25, 2022 (HealthDay News) — Adults who increase their alcohol consumption may have a higher risk for alcohol-related cancers and all cancers versus adults who had sustained quitting or reduced levels of drinking, according to a study p…
Learn MoreU.S. College Students Face COVID-19-Related Stressors
THURSDAY, Aug. 25, 2022 (HealthDay News) — Financial hardship and bereavement are particularly important stressors tied to psychological distress among college students during the pandemic, according to a study published in the Oct. 1 issue of the …
Learn MoreU.S. Government Extends Baby Formula Waivers, Rebates for WIC Families
THURSDAY, Aug. 25, 2022 (HealthDay News) — To help parents who use government nutrition benefits cope with an ongoing shortage of baby formula, U.S. federal officials will extend a program giving them more choice at the grocery store.Families who buy…
Learn MorePatterns of Undiagnosed Diabetes Examined in U.S. Adults
THURSDAY, Aug. 25, 2022 (HealthDay News) — Undiagnosed diabetes may be less of a problem than previously thought, according to a study published online July 11 in Diabetes Care.
Michael Fang, Ph.D., from Johns Hopkins University in Baltimore, and…
Learn MoreFew Excess Deaths Seen in Massachusetts During Omicron Surge
THURSDAY, Aug. 25, 2022 (HealthDay News) — Few excess deaths were reported in Massachusetts during the period of predominance of BA.2, BA.2.12.1, BA.4, and BA.5 subvariants, despite a surge of severe acute respiratory syndrome coronavirus 2 (SARS-…
Learn MoreRates of Severe COVID-19 Lower With Nirmatrelvir in ≥65s
THURSDAY, Aug. 25, 2022 (HealthDay News) — For adults aged 65 years or older, nirmatrelvir is associated with reduced rates of hospitalization and death due to COVID-19, according to a study published online Aug. 24 in the New England Journal of Me…
Learn MoreFactors Associated With Prevalence of Multiple Sclerosis Explored
THURSDAY, Aug. 25, 2022 (HealthDay News) — Variations in the prevalence of multiple sclerosis (MS) are at least partly due to sociodemographic, health systems, and neurology-specific factors, according to a study published online Aug. 24 in Neurology…
Learn MoreOlokizumab Tops Placebo for RA Patients Receiving Methotrexate
THURSDAY, Aug. 25, 2022 (HealthDay News) — Olokizumab is superior to placebo and noninferior to adalimumab in patients with rheumatoid arthritis receiving maintenance methotrexate, according to a study published in the Aug. 25 issue of the New Englan…
Learn More